Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 60

1.

Assessment of trends in cervical cancer screening rates using healthcare claims data: United States, 2003-2014.

Watson M, Benard V, Flagg EW.

Prev Med Rep. 2018 Feb 2;9:124-130. doi: 10.1016/j.pmedr.2018.01.010. eCollection 2018 Mar.

2.

Cervical cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.

Benard VB, Watson M, Saraiya M, Harewood R, Townsend JS, Stroup AM, Weir HK, Allemani C.

Cancer. 2017 Dec 15;123 Suppl 24:5119-5137. doi: 10.1002/cncr.30906.

PMID:
29205300
3.

Cervical cancer screening in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) in four US-Affiliated Pacific Islands between 2007 and 2015.

Senkomago V, Royalty J, Miller JW, Buenconsejo-Lum LE, Benard VB, Saraiya M.

Cancer Epidemiol. 2017 Oct;50(Pt B):260-267. doi: 10.1016/j.canep.2017.04.011.

4.

National assessment of HPV and Pap tests: Changes in cervical cancer screening, National Health Interview Survey.

Watson M, Benard V, King J, Crawford A, Saraiya M.

Prev Med. 2017 Jul;100:243-247. doi: 10.1016/j.ypmed.2017.05.004. Epub 2017 May 11.

PMID:
28502575
5.

Cervical Cancer Screening and Incidence by Age: Unmet Needs Near and After the Stopping Age for Screening.

White MC, Shoemaker ML, Benard VB.

Am J Prev Med. 2017 Sep;53(3):392-395. doi: 10.1016/j.amepre.2017.02.024. Epub 2017 May 1.

PMID:
28473240
6.

Understanding Barriers to Cervical Cancer Screening in Women With Access to Care, Behavioral Risk Factor Surveillance System, 2014.

Crawford A, Benard V, King J, Thomas CC.

Prev Chronic Dis. 2016 Nov 10;13:E154. doi: 10.5888/pcd13.160225.

7.

Population-Based Incidence Rates of Cervical Intraepithelial Neoplasia in the Human Papillomavirus Vaccine Era.

Benard VB, Castle PE, Jenison SA, Hunt WC, Kim JJ, Cuzick J, Lee JH, Du R, Robertson M, Norville S, Wheeler CM; New Mexico HPV Pap Registry Steering Committee.

JAMA Oncol. 2017 Jun 1;3(6):833-837. doi: 10.1001/jamaoncol.2016.3609.

8.

Change in Provider Beliefs Regarding Cervical Cancer Screening Intervals After an Educational Intervention.

Benard VB, Greek A, Roland KB, Hawkins NA, Lin L, Saraiya M.

J Womens Health (Larchmt). 2016 May;25(5):422-7. doi: 10.1089/jwh.2015.5706. Epub 2016 Apr 20.

PMID:
27096534
9.

Changes in Knowledge and Beliefs About Human Papillomavirus and Cervical Cancer Screening Intervals in Low-Income Women After an Educational Intervention.

Roland KB, Benard VB, Greek A, Hawkins NA, Lin L.

J Prim Care Community Health. 2016 Apr;7(2):88-95. doi: 10.1177/2150131915624869. Epub 2016 Jan 13.

10.

Racial and ethnic differences in human papillomavirus positivity and risk factors among low-income women in Federally Qualified Health Centers in the United States.

Lin L, Benard VB, Greek A, Hawkins NA, Roland KB, Saraiya M.

Prev Med. 2015 Dec;81:258-61. doi: 10.1016/j.ypmed.2015.08.027. Epub 2015 Sep 9.

11.

Communication practices about HPV testing among providers in Federally Qualified Health Centers.

Lin L, Benard VB, Greek A, Roland KB, Hawkins NA, Saraiya M.

Prev Med Rep. 2015;2:436-439.

12.
13.

Erratum to: Provider management of equivocal cervical cancer screening results among underserved women, 2009-2011: follow-up of atypical squamous cells of undetermined significance.

Watson M, Benard V, Lin L, Rockwell T, Royalty J.

Cancer Causes Control. 2015 May;26(5):765. doi: 10.1007/s10552-015-0589-1. No abstract available.

PMID:
25924587
14.

Clinical outcomes of mammography in the National Breast and Cervical Cancer Early Detection Program, 2009-2012.

White A, Miller J, Royalty J, Ryerson AB, Benard V, Helsel W, Kammerer W.

Cancer Causes Control. 2015 May;26(5):723-32. doi: 10.1007/s10552-015-0567-7. Epub 2015 Mar 26.

15.

Provider management of equivocal cervical cancer screening results among underserved women, 2009-2011: follow-up of atypical squamous cells of undetermined significance.

Watson M, Benard V, Lin L, Rockwell T, Royalty J.

Cancer Causes Control. 2015 May;26(5):759-64. doi: 10.1007/s10552-015-0549-9. Epub 2015 Mar 21. Erratum in: Cancer Causes Control. 2015 May;26(5):765.

16.

Vital signs: cervical cancer incidence, mortality, and screening - United States, 2007-2012.

Benard VB, Thomas CC, King J, Massetti GM, Doria-Rose VP, Saraiya M; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Nov 7;63(44):1004-9.

17.

Demographic factors associated with overuse of Pap testing.

Kepka D, Breen N, King JB, Meissner HI, Roland KB, Benard VB, Saraiya M.

Am J Prev Med. 2014 Nov;47(5):629-33. doi: 10.1016/j.amepre.2014.07.034. Epub 2014 Aug 27.

PMID:
25175763
18.

Primary care providers human papillomavirus vaccine recommendations for the medically underserved: a pilot study in U.S. Federally Qualified Health Centers.

Roland KB, Benard VB, Greek A, Hawkins NA, Saraiya M.

Vaccine. 2014 Sep 22;32(42):5432-5. doi: 10.1016/j.vaccine.2014.07.098. Epub 2014 Aug 12.

19.

National Breast and Cervical Cancer Early Detection Program data validation project.

Eheman CR, Leadbetter S, Benard VB, Blythe Ryerson A, Royalty JE, Blackman D, Pollack LA, Adams PW, Babcock F.

Cancer. 2014 Aug 15;120 Suppl 16:2597-603. doi: 10.1002/cncr.28825.

20.

Using data to effectively manage a national screening program.

Yancy B, Royalty JE, Marroulis S, Mattingly C, Benard VB, DeGroff A.

Cancer. 2014 Aug 15;120 Suppl 16:2575-83. doi: 10.1002/cncr.28821.

Supplemental Content

Loading ...
Support Center